APVO icon

Aptevo Therapeutics
APVO

hedge funds and large institutions have $37.4M invested in Aptevo Therapeutics in 2018 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $
Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$6.28M
2
-$3.99M
3
-$2.45M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$2.42M
5
BlackRock
BlackRock
New York
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$162K
27
$148K
28
$108K
29
$103K
30
$103K
31
$95K
32
$94K
33
$92K
34
$82K
35
$78K
36
$73K
37
$69K
38
$69K
39
$68K
40
$63K
41
$61K
42
$57K
43
$56K
44
$39K
45
$28K
46
$18K
47
$17K
48
$15K
49
$14K
50
$12K
1
2
3